Navigation Links
Genetic Research Sheds Light on Adrenal Gland Tumor Risk
Date:12/14/2010

TUESDAY, Dec. 14 (HealthDay News) -- Scientists report that they have advanced their knowledge of genetic mutations associated with adrenal gland tumors by identifying 13 new potential variations.

Tumors called pheochromocytomas can affect the adrenal gland, which is located above the kidney. These tumors -- which are usually benign but can also be cancerous -- cause the adrenal gland to produce too much adrenaline, resulting in high blood pressure, headaches, heart palpitations, nausea and vomiting.

In the new study, which included nearly 1,000 people, the researchers identified 19 mutations in the FP/TMEM127 gene that may be associated with pheochromocytomas in the adrenal gland.

"Of these, 19 mutations found in 20 patients were considered of potential pathogenic significance. Thirteen of these variants were [new], while the remainder had been previously reported," Li Yao, of the University of Texas Health Science Center at San Antonio, and colleagues wrote in the report published in the Dec. 15 issue of the Journal of the American Medical Association.

The average age of patients when they developed FP/TMEM127-mutated tumors was 42.8 years and median (midpoint) age was 41.5 years.

"These observations support the existence of additional pheochromocytoma susceptibility genes, which may account for some of the genetically undefined cases," the authors wrote in a news release from the journal's publisher.

More information

The American Urological Association has more about pheochromocytoma.

-- Robert Preidt

SOURCE: Journal of the American Medical Association, news release, Dec. 14, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Rare Genetic Syndrome May Increase Colon Cancer Risk
2. Chinese Study Suggests New Way to Test for Genetic Diseases
3. New discovery prevents symptoms of rare genetic disorder
4. Genetic mutations associated with increased PSA and prostate cancer
5. Novel genetic mutation that causes the most common form of eye cancer discovered
6. Rare, Severe Form of Morning Sickness Appears to Be Genetic
7. Our normal genetics may influence cancer growth, too
8. Academies of science call for amendments to impracticable Genetic Diagnostics Act
9. New research shows genetic test for lung cancer risk prompts smokers to quit
10. Genetic Deletion Linked to Raised Risk of Autism, Schizophrenia
11. ASHG 2010: New research on implications of direct-to-consumer and clinical genetic testing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Research Sheds Light on Adrenal Gland Tumor Risk
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... In Madeira ... the mainland by a single drawbridge, citizens formed an organization, Madeira Beach United, to ... traffic and change the small town center to a high rise urban environment. , ...
(Date:5/26/2016)... ... May 26, 2016 , ... Women’s athletic apparel company ... second pop-up shop for three consecutive weekends. The pop-up shop is a great ... community, a community full of women who appreciate the most premium goods and ...
(Date:5/25/2016)... ... May 26, 2016 , ... The United States Food and Drug ... in both men and women. To date, the company is the first and only ... any adult who suffers with androgenetic alopecia. , “This new level of clearance ...
(Date:5/25/2016)... ... May 25, 2016 , ... Extremity ... Tennessee locations to streamline patient check-in and post visit surveys. , “The Phreesia ... patient care. It has revolutionized the check-in process for our clinic network, providing ...
(Date:5/25/2016)... ... May 25, 2016 , ... A new update to Xsens ... all by utilizing a common Wi-Fi network and a mobile device. When paired with ... location with Wi-Fi, and use a mobile device to control the recording. , ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... PUNE, India , May 25, 2016 /PRNewswire/ ... Pipeline Review, H1 2016"market research report that provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:5/24/2016)... 24, 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei ... ‚ausgezeichneter plus guter , ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) ... positive Daten von der MORA-Studie der Phase III ...
(Date:5/24/2016)... ARANZ Medical  Ltd a specialist ... has been named the Coretex Hi-Tech Emerging Company of the ... Dr Bruce Davey , CEO of ARANZ Medical says, ... good to be recognised for the work we are doing ... in 35 countries around the world from Sub-Saharan Africa through ...
Breaking Medicine Technology: